Company / Operating Income
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$553.9M
FY2025
5-year range
-$553.9M / -$210.4M
FY2021-FY2025
Trend
-16.8%
vs FY2024
Sector context
#152 of 156
Health Care
What the data says
Among 156 Health Care companies, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is in the bottom 3% for operating income. Operating Income has declined for 6 consecutive years, from -$101M in FY2019 to -$554M in FY2025.
Based on SEC 10-K filings.
-$554M in FY2025.
Declined from -$334M to -$554M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 156This company -$553.9M Sector average $733.1M
▼
-175.6% below sector average
Key checks
Key Insights
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s operating income has declined for 6 consecutive years.
- In FY2025, operating income decreased 16.8% year-over-year.
- Ranks #152 out of 156 companies in the Health Care sector.
- Peak operating income was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$553.9M | -16.8% |
| FY2024 | -$474.3M | -41.8% |
| FY2023 | -$334.5M | -8.9% |
| FY2022 | -$307.2M | -46.0% |
| FY2021 | -$210.4M | -101.6% |
| FY2020 | -$104.4M | -3.8% |
| FY2019 | -$100.5M | +0.4% |
| FY2018 | -$101.0M | -12.5% |
| FY2017 | -$89.8M | -26.0% |
| FY2016 | -$71.2M | +8.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026